000 01559 a2200457 4500
005 20250513045904.0
264 0 _c19950323
008 199503s 0 0 eng d
022 _a1120-009X
024 7 _a10.1080/1120009x.1994.11741171
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPanetta, A
245 0 0 _aCombined chemo-immuno-hormonotherapy of advanced renal cell carcinoma.
_h[electronic resource]
260 _bJournal of chemotherapy (Florence, Italy)
_cOct 1994
300 _a349-53 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aEpirubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xadministration & dosage
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMedroxyprogesterone Acetate
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aRecombinant Proteins
650 0 4 _aSurvival Rate
650 0 4 _aVinblastine
_xadministration & dosage
700 1 _aMartoni, A
700 1 _aGuaraldi, M
700 1 _aTamberi, S
700 1 _aCasadio, M
700 1 _aLelli, G
700 1 _aPannuti, F
773 0 _tJournal of chemotherapy (Florence, Italy)
_gvol. 6
_gno. 5
_gp. 349-53
856 4 0 _uhttps://doi.org/10.1080/1120009x.1994.11741171
_zAvailable from publisher's website
999 _c7860536
_d7860536